Skin topical composition
By using a combination of porous particles, wax, carbon chain oil and surfactant in solid detergents, the stability problems caused by phase separation of solid detergents are solved, and the effects of high cleaning force, stability and comfort of use are achieved.
Patent Information
- Application Number
- JP2023556886
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-03-18
- Filing Date
- 2022-03-11
- Publication Date
- 2025-04-21
- Estimated Expiration
- 2042-03-11
AI Technical Summary
The existing solid detergent composition contains solid and liquid components, and there is a problem of phase separation, resulting in poor stability, easily deforming and degrading of cleaning performance due to changes in external mechanical forces and temperature.
Porous particles with surface pores are used as solid particles, and the rinsing agent composed of wax and carbon chain oil, plus surfactant, is controlled within 5% of the total weight.
It improves the cleaning power and comfort of detergents, enhances stability, prevents phase separation, maintains cleaning performance and feeling, and is suitable for a variety of external forces and temperature changes.
Smart Images

Figure 0007665775000004 
Figure 0007665775000005 
Figure 0007665775000001
Abstract
Description
[Technical field]
[0001] The present invention relates to a cosmetic composition for cleansing the skin or a makeup remover composition. In particular, the present invention relates to a solid cleansing composition that contains little or substantially no water. [Background technology]
[0002] 2. Description of the Related Art Skin cleansing compositions have been known so far as they are capable of cleaning and removing aged stratum corneum, oily secretions, dirt, cosmetics, and the like from human skin.
[0003] Such compositions may generally exist as aqueous compositions, such as liquids, semi-solids (e.g., gels), etc. Conventional personal cleaning care compositions include makeup removers, facial cleansers, shaving agents, etc. They may also generally contain one or more ingredients (e.g., fragrances, preservatives, surfactants, etc.). In recent years, facial cleansers (including makeup removers) have become the subcategory with the highest penetration rate among facial skin care products in many markets. In addition to their cleansing action, such compositions may remove moisture from the skin during use, causing the skin to become too dry or rough, resulting in an unsatisfactory feel when used.
[0004] On the other hand, there are compositions that exist as solids that contain little or substantially no water, and when such compositions are applied to human skin, they can spread on the skin by external force and exert a cleansing effect. For example, cleansing agents generally called "soft solids" can give users a soft and refreshing feeling.
[0005] Patent Document 1 describes a solid anhydrous composition comprising hydrophobic aerogel particles, at least one wax having a melting point of 60° C. or higher, at least one hydrocarbon oil, and at least one nonionic surfactant. The composition has improved makeup removing power, cleaning power, and skin improving effect, is easy to carry, and can maintain good makeup removing effect. In addition, the composition has the hardness required to be compatible with the necessary equipment.
[0006] Patent Document 2 describes a solid anhydrous composition comprising a) at least one hydrophobic polymer selected from the group consisting of ester-terminated poly(ester-amide)s and mixtures thereof, b) at least one hydrocarbon-based oil, and c) at least one nonionic surfactant, which is used for cleansing keratinous materials and / or removing makeup.
[0007] Although some research has been conducted so far on the detergency, usability, makeup removing power and rinsability of anhydrous solid detergent compositions, such solid compositions contain components that are solid at room temperature (e.g., wax, etc.) and components that are liquid at room temperature (e.g., liquid oil components, etc.), and therefore have stability problems due to phase separation during production, transportation, storage and even use. This point has not yet been fully recognized or reported. [Prior art documents] [Patent documents]
[0008] [Patent Document 1] CN106852117A [Patent Document 2] CN110062619A Summary of the Invention [Problem to be solved by the invention]
[0009] As described above, the detergency, usability, and rinsability of solid detergent compositions have been studied in the prior art. However, the inventors have conducted further research over a long period of time and found that stability problems may occur due to the presence of various components and oils that are solid at room temperature and are used in solid compositions to satisfy the above-mentioned usage characteristics.
[0010] For example, the solid composition may be subjected to external influences such as vibration (e.g., standing in a state different from the normal stable form) and temperature change during production, transportation, storage, and even use, which may cause phase separation between the solid components (including solid wax-like components) and liquid components such as oils, resulting in deterioration of appearance, usability, and even detergency. In particular, such a phenomenon becomes particularly noticeable after the solid composition has been subjected to a large temperature difference for a long time.
[0011] Therefore, the present invention provides a solid cleansing composition that contains little or substantially no water, and has good cleansing properties, a comfortable feel when used and easy to rinse off, while also having improved stability and being able to prevent phase separation due to the influence of external mechanical forces or temperature changes. [Means for solving the problem]
[0012] As a result of intensive research, the present inventors have found that the above problems can be solved by implementing the following invention.
[0013] [1] First, the present invention provides a) solid particles having porous particles with open pores on the surface thereof, the primary particles having an average particle size of 0.5 to 20 μm; b) at least one wax; c) at least one carbon chain based oil; d) at least one surfactant, The present invention provides a skin external preparation composition, wherein the composition may optionally contain water, and the content of the water is 5% or less based on the total mass of the composition. [2] The composition according to [1], wherein the average pore size of open pores on the surface of the solid particles of component a) is 7.5 to 50 nm. [3] The composition according to [1] or [2], wherein the solid particles of component a) are one or more selected from silica, surface-modified silica, and organic polymer-based particles. [4] The solid particles of component a) have an oil absorption rate of 300% or less and / or a specific surface area of 80 to 400 m 2 The composition according to any one of [1] to [3], wherein the molecular weight is 1.0 to 1.0 g. [5] The composition according to any one of [1] to [4], which is substantially free of water. [6] The composition according to any one of [1] to [5], wherein the wax of the component b) is one or more selected from natural vegetable waxes and synthetic waxes. [7] The composition according to any one of [1] to [6], wherein the content of component a) is 0.1 to 10%, the content of component b) is 1 to 30%, the content of component c) is 50 to 95%, and the content of component d) is 3 to 30%, relative to the total mass of the composition. [8] A cleaning agent comprising the composition according to any one of [1] to [7]. Effect of the Invention
[0014] By implementing the above invention, the present invention can achieve the following effects. 1) The skin topical composition according to the present invention has good skin cleansing power and an excellent feel when used, and also has satisfactory rinsability. 2) The skin external preparation composition according to the present invention can prevent problems of deterioration of uniformity due to external mechanical forces or temperature changes, and has improved stability over time. [Brief description of the drawings]
[0015] [Figure 1] FIG. 1 is a temperature control chart for a stability test in an embodiment of the present invention. [Diagram 2] FIG. 2 is a diagram showing how a test sample was placed (vertical / horizontal) during the evaluation test of an embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] The configuration of the present invention will be described in detail below. The following description of the configuration of the present invention is based on representative embodiments and specific examples of the present invention, but the present invention is not limited to these embodiments and specific examples. In addition, the following description will be given.
[0017] In this specification, a numerical range expressed as "numerical value A to numerical value B" means a range including the endpoints A and B.
[0018] In this specification, a numerical range expressed as "greater than or equal to" or "less than or equal to" means a numerical range that includes the indicated number.
[0019] In this specification, the term "may" means that the treatment may or may not be carried out.
[0020] As used herein, "optionally" or "optionally" refers to the use or non-use of an element such as a substance, ingredient, step, application condition, etc.
[0021] In this specification, "powder" and "particles" have the same physical meaning. "Solid powder particles" and "solid particles" have the same physical meaning.
[0022] In this specification, "room temperature" means an indoor ambient temperature of "25°C."
[0023] In this specification, all unit names are international standard unit names, and unless otherwise specified, "%" means percentage by weight or mass.
[0024] In this specification, "resin" and "rubber" have different meanings, and the two are distinguished by the presence or absence of "elasticity." Usually, the former does not have obvious elasticity, and the latter has obvious elasticity.
[0025] In the present invention, a "solid" composition is an expression that represents the form of a composition at 25° C. A "solid" is a composition having a hardness of 30 Nm when measured at 25° C. and atmospheric pressure (760 mmHg). -1The above means that the specific test method may be a method described in a patent document or prior art.
[0026] As used herein, "substantially free of water" means that in some embodiments of the invention, no water is added when the ingredients are mixed, meaning that any water that may be present in the composition comes only from trace amounts of moisture that are unavoidably contained in the raw materials.
[0027] As used herein, "some / preferred embodiments," "another (preferred) embodiment," "embodiment," and the like, mean that the particular elements (e.g., features, structures, properties, and / or characteristics) described in connection with the embodiment are included in at least one embodiment described herein and may or may not be present in other embodiments. However, these elements may be combined in any suitable manner in the various embodiments.
[0028] The present invention relates to a skin external preparation composition. In some embodiments, the skin cleansing composition contains little or substantially no water.
[0029] The skin external preparation composition of the present invention mainly contains solid particles (hereinafter also referred to as "solid powder particles") which are porous powders having open pores on the surface, a necessary wax component, an oil component, and a surfactant. In some preferred embodiments, the content of the water is 5% or less based on the total mass of the composition.
[0030] (solid powder particles) The skin external preparation composition of the present invention contains solid powder particles. The solid powder particles of the present invention are porous solid particles or porous solid powders having open pores on the surface.
[0031] In the present invention, the porous solid particles or porous solid powders are present mainly as primary particles in the skin external preparation composition. In some embodiments, the solid particles or powders present as primary particles account for 90% or more, preferably 95% or more, more preferably 98% or more of the total mass of all particles or powders.
[0032] In the present invention, the term "primary particles" refers to particles that exist in the form of a single particle, and is distinguished from "secondary particles" in terms of their state of existence. "Secondary particles" refer to aggregated particles formed when multiple solid particles with very small particle sizes gather together due to high surface energy, and examples of such particles include substances such as aerogel.
[0033] In some embodiments of the present invention, the primary particles of the present invention have an average primary particle size (D50) of 0.5 to 20 μm, preferably 3 to 18 μm, and more preferably 4 to 15 μm. If the average particle size of the primary particles is too small, the primary particles tend to aggregate to form secondary particles, which reduces the stability of the composition of the present invention. On the other hand, if the average particle size of the primary particles is too large, it may adversely affect the feel of use of the skin topical composition of the present invention, for example, causing excessive roughness or excessive friction.
[0034] The porous solid particles or powder of the present invention can be selected from silica particles having an open pore structure on the surface, surface-modified silica particles, organic polymer particles, or mixtures thereof. From the viewpoints of usability, thermal expansion / contraction resistance of the material, and safety, the porous solid particles or powder of the present invention are preferably silica particles having an open pore structure on the surface. In some embodiments, the porous solid particles or powder of the present invention may be hydrophobic particles or powders.
[0035] Furthermore, the surface-modified silica may be silica particles whose surface has been modified with a resin or rubber, such as silicone resin, silicone rubber, etc. The organic polymer particles may be selected from crosslinked or non-crosslinked organic polymer particles, such as particles made of (meth)acrylic resin, polyamide resin (nylon powder), polyethylene, polystyrene, copolymer resin of styrene and (meth)acrylic acid, benzoguanamine resin, polytetrafluoroethylene, cellulose, silicone resin, silicone rubber, etc., or composite particles made of two or more of these substances (for example, core-shell).
[0036] The porous solid particles or powder of the present invention have an open pore structure on the surface. The term "open pore" refers to holes that exist on the surface of the particles or powder and communicate with the outside.
[0037] In some embodiments, the average pore diameter of the pores is 7.5 nm or more, or 8 nm or more, or 10 nm or more, or 12 nm or more. Regarding the upper limit of the average pore diameter of the pores, in some embodiments, the average pore diameter of the pores is 50 nm or less, or 30 nm or less, or 20 nm or less. Furthermore, in some preferred embodiments of the present invention, the average pore diameter of the pores is preferably 7.5 to 15 nm.
[0038] The average pore size of the surface pores in the present invention can be measured by a known method. Usually, standard gas adsorption analysis tests can be performed by nitrogen adsorption at liquid nitrogen temperature, and the resulting data can be processed by the Barrett-Joyner-Halenda method (abbreviated as BJH method) to obtain the final measured value.
[0039] In some embodiments, the specific surface area of the porous solid particles of the present invention is 400 m 2 / g or less, preferably 80 to 400m 2 / g or 100~400m 2 / g, and more preferably 200 to 350 m 2 / g. The specific surface area of the present invention can be determined by the BET (Brunauer-Emmett-Teller) nitrogen adsorption method described in the Journal of the American Chemical Society (vol. 60, p. 309, February 1938) and the international standard ISO 5794 / 1 (Appendix D). The BET specific surface area corresponds to the total specific surface area of the particles under test.
[0040] The oil absorption of the porous solid particles of the present invention is not particularly limited, but is related to the specific surface area and particle size. However, from the viewpoint of the stability of the skin external preparation composition of the present invention, the porous solid particles of the present invention have an oil absorption of 300% or less, preferably 50-250% or 100-250%. The oil absorption can be measured by known techniques, such as the wet point method or the method for measuring the oil absorption of powders described in the standard NF T 30-022.
[0041] In the present invention, it is believed that the porous solid particles or solid powder having the above-mentioned configuration will be useful in preventing the problem of decreased stability due to phase separation when mixed with other components to be incorporated in the topical skin composition of the present invention.
[0042] As a result of the study of the present invention, it is presumed that the above-mentioned effect is caused by the following mechanism. In the skin external preparation composition of the present invention, a wax component is mainly used as a solid component at room temperature, and is mixed with an oily component, solid particles, a surfactant, etc. During mixing, the oily component penetrates into the open pores on the surface of the solid particles, that is, the open pore structure on the surface exhibits the effect of fixing the oily component that enters. As a result, even if the obtained skin external preparation composition is subjected to external mechanical force stimulation (such as vibration during transportation or use) or temperature change stimulation (such as temperature change due to storage conditions or regional or seasonal differences), the oily component does not separate and precipitate from the solid phase of the skin external preparation composition, and the stability of the entire skin external preparation composition of the present invention is improved, and the original feeling of use and cleaning power are maintained. In addition, this fixing effect is well exhibited even when the content of porous solid particles is 10% or less.
[0043] (Wax component) The skin external preparation composition of the present invention contains a wax component.
[0044] In the present invention, the wax component refers to a lipid compound component that is solid at room temperature.
[0045] In some embodiments of the present invention, the wax component has a melting point of 30° C. or higher, preferably 50° C. or higher, more preferably 60° C. or higher, and even more preferably 65° C. or higher. The melting point of the present invention can be determined by the temperature of the maximum endothermic peak observed in thermal analysis (DSC) according to standard ISO 11357-3 (1999). Specifically, the melting point of the wax component can be measured using a differential scanning calorimeter (DSC), such as the calorimeter sold by TA Instruments under the trade name "MDSC 2920".
[0046] The wax component used in the skin external preparation composition of the present invention can be selected from natural animal / vegetable waxes and synthetic waxes, specifically, waxes of animal, vegetable, mineral or synthetic origin that are solid at room temperature, and mixtures thereof, and preferably one or more of natural vegetable waxes and synthetic waxes.
[0047] Specific examples of the wax component used in the present invention include hydrocarbon waxes, such as beeswax, lanolin wax, insect wax (Chinese insect wax), rice bran wax, carnauba wax, candelilla wax, ouricury wax, esparto grass wax, berry wax, shellac wax, Japanese wax, sumach wax, montan wax, orange wax, lemon wax, microcrystalline wax, ozokerite, polyethylene wax, polymethylene wax, 12-hydroxystearic acid, glyceryl trihydroxystearate, waxes and waxy copolymers obtained by Fischer-Tropsch synthesis, esters thereof, and mixtures thereof. Waxes obtained by catalytic hydrogenation of animal or vegetable oils containing linear or branched C8 to C32 fatty chains may also be included. Among these waxes, particular mention may be made of isomerized jojoba oils, such as the trans-isomerized partially hydrogenated jojoba oil from Desert Whale, hydrogenated sunflower oil, hydrogenated castor oil, hydrogenated coconut oil, hydrogenated lanolin oil, and bis(1,1,1-trimethylolpropane) tetrastearate sold under the name "Hest" by Heterene.
[0048] In some embodiments of the present invention, waxes obtained by hydrogenation of castor oil esterified with cetyl alcohol (e.g., Phytowax ricin, available from Sophim), C20-C40 alkyl (hydroxystearoxy)stearates (e.g., Kester Wax K82, Hydroxypolyester K82 and Kester Wax K80, available from Koster Keunen), linear hydroxylated C18-C24 fatty acids (e.g., 12-hydroxystearic acid, available from Thai Kawaken under the trade name 12-Hydroxystearic Acid Premium Grade 12H-P) can be used.
[0049] In some embodiments of the present invention, the skin topical composition according to the present invention comprises at least one wax component having a melting point of 60° C. or higher. Such waxes include carnauba wax, ozokerite, microcrystalline wax, 12-hydroxystearic acid, polyethylene wax (e.g., Performalene 500L Polyethylene or Performalene 400L Polyethylene, manufactured by New Phase Technologies, or Asensa SC 211, manufactured by Honeywell), polymethylene wax (e.g., Cirebelle 108, manufactured by Cirebelle), beeswax, candelilla wax, hydroxyoctacosyl hydroxystearate, hydrogenated castor oil, hydrogenated jojoba oil, rice bran wax, polyglycerinated beeswax, octacosyl stearate, ceresin wax, ceresin 108 ... wax), (hydroxystearoxy)stearic acid C20-C40 alkyl wax, 12-hydroxystearic acid, polyvinyl alcohol wax, Fischer-Tropsch wax, wax obtained by hydrogenation of castor oil esterified with cetyl alcohol, Ouricury wax, Montan wax, glyceryl trihydroxystearate with the INCI name Trihydroxystearin (e.g. Thixcin R, trade name, manufactured by Elementis), and mixtures thereof.
[0050] In another embodiment of the present invention, the skin external preparation composition according to the present invention comprises at least one wax having a melting point of 65° C. or higher. Such waxes can be selected from carnauba wax, ozokerite, microcrystalline wax, 12-hydroxystearic acid, polymethylene wax (e.g., Cirebelle 108), candelilla wax, hydroxyoctacosyl hydroxystearate, hydrogenated castor oil, hydrogenated jojoba oil, rice bran wax, polyglycerinated beeswax, octacosyl stearate, ceresin wax, (hydroxystearoxy)stearic acid C20-C40 alkyl wax, polyvinyl alcohol wax, Fischer-Tropsch wax, wax obtained by hydrogenation of castor oil esterified with cetyl alcohol, ouricury wax, montan wax, glyceryl trihydroxystearate with the INCI name trihydroxystearin (e.g., Thixcin R, trade name, Elementis), and mixtures thereof.
[0051] The above wax components can be used alone or in combination. For example, multiple wax components having the same or similar melting points may be used in combination, or multiple wax components having different melting points may be used in combination.
[0052] In a more preferred embodiment of the present invention, the composition according to the present invention comprises at least one wax component having a melting point of 65° C. or higher selected from carnauba wax, ozokerite, microcrystalline wax, polymethylene wax, 12-hydroxystearic acid, candelilla wax, Fischer-Tropsch wax, hydrogenated jojoba oil and glyceryl trihydroxystearate, and mixtures thereof.
[0053] (Carbon chain oil) In the present invention, the skin external preparation composition contains an oil component containing at least one carbon chain oil.
[0054] In the present invention, "carbon chain-based" means that the molecular skeletal structure of the oil is mainly formed by carbon-carbon bonds, and the skeletal structure includes a main chain structure and / or a branched chain structure, which distinguishes it from silicon chain-based oils.
[0055] The carbon chain oil of the present invention is usually a liquid oil at room temperature and 1 atmospheric pressure, and may be a volatile oil or a non-volatile oil, but preferably a non-volatile liquid oil is used. In this specification, "non-volatile liquid oil" means a non-solid liquid oil that does not show volatility at room temperature (25°C) and normal pressure (1 atmospheric pressure) (for example, includes oils with a boiling point of about 200°C or higher at normal pressure) and has fluidity at room temperature and normal pressure.
[0056] The carbon chain oil of the present invention may be a liquid oil derived from the petrochemical industry or may be a liquid oil derived from animals or plants, and specifically, it can be selected from hydrocarbon oils, vegetable oils, mineral oils, ester oils, ether oils, etc.
[0057] Specific examples include liquid oils and fats such as linseed oil, camellia oil, macadamia nut oil, corn oil, olive oil, avocado oil, camellia oil, castor oil, safflower oil, apricot kernel oil, cinnamon oil, jojoba oil, grape oil, sunflower oil, wheat germ oil, rice germ oil, rice bran oil, cottonseed oil, soybean oil, peanut oil, tea seed oil, evening primrose oil, egg yolk oil, liver oil, triglycerin, glyceryl trioctanoate, citric acid esters, and glyceryl triisopalmitate; octanoic acid esters such as cetyl octanoate and glyceryl trioctanoate; and tri-2-ethylhexyl glyceryl triisopalmitate. isooctanoic acid esters such as glyceryl tetraethylhexanoate, pentaerythritol tetra-2-ethylhexanoate, and cetyl (2-ethylhexanoate); lauric acid esters such as hexyl laurate; myristate esters such as isopropyl myristate and octyldodecyl myristate; palmitic acid esters such as octyl palmitate; stearic acid esters such as isocetyl stearate; isostearic acid esters such as isopropyl isostearate; isopalmitic acid esters such as octyl isopalmitate; oleic acid esters such as oleic acid esters; ester oils such as oleic acid esters such as isodecyl adipate, adipic acid diesters such as diisopropyl adipate, sebacic acid diesters such as diethyl sebacate, and diisostearyl malate; linear / branched hydrocarbon oils or polyolefin oils having 8 to 30 carbon atoms, for example, isododecane, isohexadecane, hydrogenated polyisobutylene, liquid paraffin, squalane, and other hydrocarbon oils; linear alcohols (for example, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, etc.) higher fatty alcohols including monostearyl glyceryl ether (batylol), 2-decyltetradecyl alcohol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, and the like; higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tall oil fatty acid, isostearic acid, linolic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and the like;Examples of the polymeric polyether oils include ether-type or polyalkylene-type polyether oils having 10 to 40 carbon atoms, such as polyoxybutylene glycol and polyoxypropylene glycol.
[0058] The carbon chain oil may be one type or a mixture of two or more types. In some preferred embodiments of the present invention, it is preferable to use a polar oil among the carbon chain oils from the viewpoint of usability and stability. In some embodiments, the content of the polar oil in the carbon chain oil is 80% or more, preferably 85% or more, and more preferably 90% or more.
[0059] Furthermore, on the condition that it does not affect the effects of the present invention, silicon chain oils such as volatile or non-volatile silicone oils can also be used as the oil component of the present invention.
[0060] Volatile silicone oils include silicone oils that are volatile at room temperature and have been used in cosmetics and the like, such as volatile linear silicone oils (volatile dimethicones) and volatile cyclic silicone oils (volatile cyclomethicones).Volatile dimethicones can be low-viscosity dimethylpolysiloxanes such as decamethyltetrasiloxane, and examples of commercially available products include KF-96L-1.5cs and KF-96L-2cs (both manufactured by Shin-Etsu Chemical Co., Ltd.).Volatile cyclomethicones include decamethylcyclopentasiloxane (D5).
[0061] In some embodiments of the present invention, the content of the carbon chain oil in the external skin preparation composition of the present invention is 80% or more, preferably 85% or more, and more preferably 90% or more, based on the total mass of the oil content.
[0062] (Surfactant) The skin external preparation composition of the present invention contains a surfactant. The type of surfactant is not particularly limited, and one or more of anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants commonly used in the art can be used.
[0063] Examples of anionic surfactants that can be used in the present invention include fatty acid soaps (e.g., sodium laurate and sodium palmitate); higher alkyl sulfates (e.g., sodium lauryl sulfate and potassium lauryl sulfate); alkyl ether sulfates (e.g., POE lauryl sulfate triethanolamine and sodium POE lauryl sulfate); N-acyl sarcosinates (e.g., sodium N-lauroyl sarcosinate); higher fatty acid amide sulfonates (e.g., sodium N-myristoyl-N-methyl taurate, sodium cocoyl methyl taurate and sodium lauroyl methyl taurate); phosphates (e.g., sodium POE oleyl ether phosphate and sodium POE stearyl ether phosphate); sulfosuccinates (e.g., sodium di-2-ethylhexyl sulfosuccinate, sodium monolauroyl monoethanolamide polyoxyethylene sulfosuccinate and sodium lauroyl methyl taurate). polypropylene glycol sulfosuccinate); alkyl benzene sulfonates (e.g., sodium linear dodecyl benzene sulfonate, linear dodecyl benzene sulfonic acid triethanolamine, and linear dodecyl benzene sulfonic acid); higher fatty acid ester sulfates (e.g., sodium hydrogenated coconut oil fatty acid glycerin sulfate); N-acyl glutamates (e.g., monosodium N-lauroyl glutamate, disodium N-stearoyl glutamate, and sodium N-myristoyl-L-glutamate); sulfated oils (e.g., turmeric oil); POE alkyl ether carboxylic acids; POE alkyl aryl ether carboxylates; α-olefin sulfonates; higher fatty acid ester sulfonates; sec-alcohol sulfates; higher fatty acid alkyl amide sulfates; sodium lauroyl monoethanolamine succinate; ditriethanolamine N-palmitoyl aspartate; and sodium caseinate.
[0064] Examples of cationic surfactants for use in the present invention include alkyl trimethyl ammonium salts (e.g., stearyl trimethyl ammonium chloride and lauryl trimethyl ammonium chloride); alkyl pyridinium salts (e.g., cetyl pyridinium chloride); distearyl dimethyl ammonium chloride, dialkyl dimethyl ammonium salts; poly(N,N'-dimethyl-3-methylene piperidinium) chloride; alkyl quaternary ammonium salts; alkyl dimethyl benzyl ammonium salts; alkyl isoquinolinium salts; dialkyl morpholine salts; POE alkyl amines; alkyl amine salts; polyamine fatty acid derivatives; amyl alcohol fatty acid derivatives; benzalkonium chloride; and benzethonium chloride.
[0065] Examples of amphoteric surfactants that can be used in the present invention include imidazoline-type amphoteric surfactants (e.g., 2-undecyl-N,N,N-(hydroxyethylcarboxymethyl)-2-imidazoline sodium salt and 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethylyloxy disodium salt); and betaine-type surfactants (e.g., 2-heptadecyl-n-carboxymethyl-n-hydroxyethylimidazolinium betaine, lauryl dimethylaminoacetic acid betaine, alkyl betaine, amido betaine, and sulfo betaine).
[0066] Examples of nonionic surfactants that may be used in the present invention include hydrophilic nonionic surfactants and lipophilic surfactants.
[0067] Examples of the hydrophilic surfactant include polyglycerol fatty acid esters [e.g., hexaglyceryl monolaurate (HLB 14.5), hexaglyceryl monomyristate (HLB 11), hexaglyceryl monostearate (HLB 9.0), hexaglyceryl monooleate (HLB 9.0), decaglyceryl monolaurate (HLB 15.5), decaglyceryl monomyristate (HLB 14.0), decaglyceryl monostearate (HLB 12.0), decaglyceryl monoisostearate (HLB 12.0), decaglyceryl monooleate]. decaglyceryl distearate (HLB 9.5), and decaglyceryl diisostearate (HLB 10.0)]; polyoxyethylene glycerin fatty acid esters (e.g., polyoxyethylene ("POE") (5) glyceryl monostearate (HLB 9.5), POE (15) glyceryl monostearate (HLB 13.5), POE (5) glycerol monooleate (HLB 9.5), and POE (15) glyceryl monooleate (HLB 14.5)]; polyoxyethylene sorbitan fatty acid esters [e.g., POE (20) sorbitan monostearate (HLB 16.9), POE(20) sorbitan monopalmitate (HLB 15.6), POE(20) sorbitan monostearate (HLB 14.9), POE(6) sorbitan monostearate (HLB 9.5), POE(20) sorbitan tristearate (HLB 10.5), POE(20) sorbitan monoisostearate (HLB 15.0), POE(20) sorbitan monooleate (HLB 15.0), POE(6) sorbitan monooleate (HLB 10.0) and POE(20) sorbitan polyoxyethylene sorbitol fatty acid esters [e.g., POE(6) sorbitol monolaurate (HLB15.5), POE(60) sorbitol tetrastearate (HLB13.0), POE(30) sorbitol tetraoleate (HLB11.5), POE(40) sorbitol tetraoleate (HLB12.5) and POE(60) sorbitol tetraoleate (HLB14.0)); polyoxyethylene lanolin / lanolin alcohol / beeswax derivatives [e.g., POE(10) lanolin (HLB12.0), POE(20) lanolin (HLB13.0), POE(30) lanolin (HLB15.0), POE(5) lanolin alcohol (HLB12.5), POE(10) lanolin alcohol (HLB15.5), POE(20) lanolin alcohol (HLB16.0), POE(40) lanolin alcohol (HLB17.0) and POE(20) sorbitol beeswax (HLB9.5)]; polyoxyethylene castor oil / hydrogenated castor oil [e.g., POE(20) castor oil (HLB10.5), POE(40) castor oil (HLB12.5), POE( POE(50) castor oil (HLB14.0), POE(60) castor oil (HLB14.0), POE(20) hydrogenated castor oil (HLB10.5), POE(30) hydrogenated castor oil (HLB11.0), POE(40) hydrogenated castor oil (HLB13.5), POE(60) hydrogenated castor oil (HLB14.0), POE(80) hydrogenated castor oil (HLB16.5) and POE(100) hydrogenated castor oil (HLB16.5)]; polyoxyethylene sterols / hydrogenated sterols [e.g., POE(5) phytosterols (HLB9.5), POE(10) phytosterols (HL B12.5), POE(20) phytosterol (HLB15.5), POE(30) phytosterol (HLB18.0), POE(25) phytosterol (HLB14.5) and POE(30) cholestanol (HLB17.0)]; polyoxyethylene alkyl ethers [e.g., POE(2) lauryl ether (HLB9.5), POE(4.2) lauryl ether (HLB11.5), POE(9) lauryl ether (HLB14.5), POE(5.5) cetyl ether (HLB10.5), POE(7) cetyl ether (HLB1 1.5), POE(10) cetyl ether (HLB13.5), POE(15) cetyl ether (HLB15.5), POE(20) cetyl ether (HLB17.0), POE(23) cetyl ether (HLB18.0), POE(4) stearyl ether (HLB9.0), POE(20) stearyl ether (HLB18.0), POE(7) oleyl ether (HLB10.5), POE(10) oleyl ether (HLB14.5), POE(15) oleyl ether (HLB16.0), POE(20) oleyl ether (HLB17.0), POE(50) oleyl ether (HLB18.0), POE(10) behenyl ether (HLB10.0), POE(20) behenyl ether (HLB16.5), POE(30) behenyl ether (HLB18.0), POE(2)(C. 12-15 ) Alkyl ether (HLB9.0), POE(4)(C 12-15 ) Alkyl ether (HLB10.5), POE(10)(C 12-15) alkyl ether (HLB 15.5), POE(5) secondary alkyl ether (HLB 10.5), POE(7) secondary alkyl ether (HLB 12.0), POE(9) alkyl ether (HLB 13.5) and POE(12) alkyl ether (HLB 14.5)]; polyoxyethylene polyoxypropylene alkyl ethers [e.g., POE(1) polyoxypropylene ("POP") (4) cetyl ether (HLB 9.5), POE(10) POP(4) cetyl ether (HLB 1 0.5), POE(20)POP(8) cetyl ether (HLB 12.5), POE(20)POP(6) decyl tetradecyl ether (HLB 11.0), and POE(30)POP(6) decyl tetradecyl ether (HLB 12.0)]; polyethylene glycol fatty acid esters [e.g., polyethylene glycol ("PEG") (10) (HLB 12.5), PEG(10) monostearate (HLB 11.0), PEG(25) monostearate (HLB 15.0), PEG(40) monostearate (HLB 16.0), PEG(40) monostearate (HLB 17.0), PEG(40) monostearate (HLB 18.0), PEG(40) monostearate (HLB 19.0), PEG(40) monostearate (HLB 20.0), PEG(40) monostearate (HLB 21.0), PEG(40) monostearate (HLB 22.0), PEG(40) monostearate (HLB 23.0), PEG(40) monostearate (HLB 24.0), PEG(40) monostearate (HLB 25.0), PEG(40) monostearate (HLB 26.0), PEG(40) monostearate (HLB 27.0), PEG(40) monostearate (HLB 28.0), PEG(40) monostearate (HLB 29.0), PEG(40) monostearate (HLB 30.0), PEG(40) monostearate (HLB 31.0), PEG(40) monostearate (HLB 32.0), PEG(40) monostearate (HLB 33.0), PEG(40) monostea PEG(45) monostearate (HLB 17.5), PEG(45) monostearate (HLB 18.0), PEG(55) monostearate (HLB 18.0), PEG(10) monooleate (HLB 11.0), PEG distearate (HLB 16.5) and PEG diisostearate (HLB 9.5)]; and (tri)polyoxyethylene glyceryl isostearate [e.g., PEG(8) glyceryl isostearate (HLB 10.0), PEG(10 ... .0), PEG(15) glyceryl isostearate (HLB 12.0), PEG(20) glyceryl isostearate (HLB 13.0), PEG(25) glyceryl isostearate (HLB 14.0), PEG(30) glyceryl isostearate (HLB 15.0), PEG(40) glyceryl isostearate (HLB 15.0), PEG(50) glyceryl isostearate (HLB 16.0 and PEG(60) glyceryl isostearate (HLB 16.0)].
[0068] Examples of lipophilic surfactants include POE(2) stearyl ether (HLB 4.0), self-emulsifying propylene glycol monostearate (HLB 4.0), glyceryl myristate (HLB 3.5), glyceryl monostearate (HLB 4.0), self-emulsifying glyceryl monostearate (HLB 4.0), glyceryl monoisostearate (HLB 4.0), glyceryl monooleate (HLB 2.5), hexaglyceryl tristearate (HLB 2.5), decaglyceryl pentastearate (HLB 3.5), decaglyceryl pentaisostearate (HLB 3.5), and pentyl isostearate (HLB 3.5). Decaglyceryl pentaoleate (HLB 3.5), sorbitan monostearate (HLB 4.7), sorbitan tristearate (HLB 2.1), sorbitan monoisostearate (HLB 5.0), sorbitan sesquiisostearate (HLB 4.5), sorbitan monooleate (HLB 4.3), POE(6) sorbitol hexastearate (HLB 3.0), POE(3) castor oil (HLB 3.0), PEG(2) monostearate (HLB 4.0), ethylene glycol monostearate (HLB 3.5) and PEG(2) stearate (HLB 4.5).
[0069] In some preferred embodiments of the present invention, it is preferred to use one or more nonionic surfactants having an HLB value of 4.5 to 20, preferably 5 to 15, from the standpoint of usability and stability.
[0070] (External skin preparation composition) The skin external preparation composition of the present invention is obtained by uniformly mixing the above-mentioned components. The mixing method is not particularly limited. Each component may be mixed at the same time, or any number of components may be mixed and then mixed with other components. In some preferred embodiments of the present invention, the solid powder particles are mixed with at least a part of the carbon chain oil, and then further mixed with other components to obtain the skin external preparation composition of the present invention.
[0071] In some embodiments, the mixing temperature may be in the range of 30 to 70°C.
[0072] The amount of the solid powder particles in the present invention can be 0.1 to 10% based on the total mass of the skin external preparation composition, preferably 0.3 to 8%, and more preferably 0.5 to 5%.
[0073] The amount of wax in the present invention can be 1 to 30% based on the total mass of the external skin preparation composition, preferably 2 to 20%, more preferably 3 to 15%, and even more preferably 3 to 10%.
[0074] The amount of the carbon chain oil in the present invention can be 50 to 95% based on the total mass of the external skin preparation composition, preferably 55 to 90%, and more preferably 60 to 85%.
[0075] The amount of the surfactant of the present invention to be blended can be 3 to 30% based on the total mass of the external skin preparation composition, and is preferably 5 to 28%, and more preferably 10 to 25%.
[0076] In some embodiments of the present invention, the water content in the skin topical preparation composition of the present invention (based on the total mass of the composition) is 5% or less, preferably 3% or less, more preferably 1% or less, and even more preferably 0.5% or less. In some preferred embodiments, the skin topical preparation composition of the present invention does not substantially contain water, or water is not added during mixing of the composition of the present invention, and the water in the composition of the present invention is derived only from the residual water inevitably contained in each component.
[0077] Furthermore, in some embodiments of the present invention, the total amount of components a) to d) can be 85% or more, preferably 90% or more, and more preferably 95% or more, based on the total mass of the topical skin preparation composition.
[0078] The hardness of the skin external preparation composition of the present invention is not particularly limited, but in some embodiments, the skin external preparation composition of the present invention has a hardness of 40 N / m or more, preferably 50 to 300 N / m. In addition, the skin external preparation composition of the present invention may or may not have a fixed shape. It may be used directly on the human body or skin, or may be used on the human body or skin by being supported on another carrier or via another carrier.
[0079] In addition to the above-mentioned components, the composition of the present invention may contain various auxiliary components suitable for use in cosmetic compositions, provided that the effects of the present invention are not impaired. Such auxiliary components include, but are not limited to, preservatives, antioxidants, complexing agents, pH adjusters (acidic or basic), fragrances, other fillers, bactericides, odor absorbers, colorants (pigments and dyes), film-forming polymers, thickeners and / or gelling agents, and active ingredients (e.g., sodium hyaluronate; plant extracts such as madecassoside). In another embodiment, the skin topical composition of the present invention is a solid having self-shaping and self-supporting properties, and therefore does not need to contain a (water-insoluble) artificial or natural polymer-based support such as a mesh, filament, or cloth.
[0080] Furthermore, the skin topical preparation composition of the present invention can be made into various cosmetic preparations such as creams, balms, and cosmetic preparations in a fixed solid or gel form, as necessary. In some preferred embodiments, the skin topical preparation composition of the present invention can be used to manufacture products for cleaning the human body or skin, and more preferably, can be used to manufacture cleansing agents for use in applications such as makeup removal. EXAMPLES
[0081] The present invention will be described below with reference to specific examples.
[0082] <Raw materials> The names and manufacturers of the raw materials of the present invention are shown in Table 1 below.
[0083] [Table 1]
[0084] Table 2 below shows the physical property data of the solid particles shown in Table 1.
[0085] [Table 2]
[0086] <Manufacturing method> [Material preparation] Material A: Put the wax into some hydrocarbon oil and heat it to 90±2℃ until it is completely melted. Material B: Mix the solid particles and the remaining oil, and stir vigorously until the particles are fully dispersed. Then add material A, keep the temperature at 85±2℃, add other raw materials in order, filter and discharge after mixing, and store.
[0087] [Filling material] The material is placed in a kettle and heated to 82±2℃, and filled once the material is fully melted. After filling, the semi-finished product is cooled to obtain a cylindrical cooled product, which is then packed into a box and stored at room temperature.
[0088] <Test Method> [Usability evaluation] The skin (face) was cleansed using the solids obtained in the following Examples and Comparative Examples, and after rinsing with water, the presence or absence of a sticky feeling was tested (average data of 20 people).
[0089] [Stability evaluation] The test specimens were placed in an oven on their side, and the oven temperature was set to 5 to 45°C, with two cycles per day, with temperatures at 5°C and 45°C maintained for two hours each. As shown in the temperature control curve in Figure 1, 28 cycles of temperature change treatment were carried out over a total of 14 days, and it was observed whether oil had seeped out onto the surface of the test specimens. The stability of the system was evaluated by carrying out the temperature change treatment with the cylinder lying on its side (instead of standing upright, see Figure 2) to simulate temperature changes under abnormal storage conditions that may occur during transportation and storage.
[0090] <Examples 1 to 3, Comparative Examples 1 and 2> Each component shown in Table 1 was prepared into a composition by the above-mentioned method, and the test was carried out.
[0091] [Table 3]
[0092] Although the present invention has been described with reference to specific examples, the present disclosure is not limited to these.
[0093] Although each embodiment of the present disclosure has been described above, the above description is illustrative and not exhaustive, and is not limited to each embodiment of the present specification. It is clear to those skilled in the art that various modifications and changes can be made without departing from the scope and spirit of each embodiment of the present specification. The terms used in the present specification are selected in order to best explain the principles, practical applications, and technical improvements in the market of each embodiment, or to enable other skilled in the art to understand each embodiment disclosed in the present specification. [Industrial Applicability]
[0094] The skin external preparation composition of the present invention can be produced and used industrially.
Claims
1. a) solid particles, the porous particles having openings on the surface, the porous particles existing as primary particles occupying 90% or more of the total mass of all particles, the primary particles having an average particle size of 0.5 to 20 μm, and the openings on the surface having an average pore size of 7.5 to 50 nm; b) at least one wax; c) at least one carbon chain based oil; d) at least one surfactant, The composition may optionally contain water, and the water content is 5% or less based on the total mass of the composition.
2. 2. The composition according to claim 1, wherein the average pore size of the open pores on the surface of the solid particles of component a) is 7.5 to 15 nm.
3. 3. The composition according to claim 1, wherein the solid particles of component a) are one or more selected from silica, surface-modified silica and organic polymer-based particles.
4. The solid particles of component a) have an oil absorption rate of 300% or less and / or a specific surface area of 80 to 400 m 2 The composition according to any one of claims 1 to 3, characterized in that:
5. The composition according to any one of claims 1 to 4, which is substantially free of water.
6. The composition according to any one of claims 1 to 5, characterized in that the wax of component b) is one or more selected from natural vegetable waxes and synthetic waxes.
7. The composition according to any one of claims 1 to 6, characterized in that, based on the total mass of the composition, the content of component a) is 0.1 to 10%, the content of component b) is 1 to 30%, the content of component c) is 50 to 95%, and the content of component d) is 3 to 30%.
8. A cleaning agent comprising the composition according to any one of claims 1 to 7.
Citation Information
Patent Citations
Solid anhydrous composition for removing the makeup on the skin
CN106852117A
Solid anhydrous composition comprising a hydrophobic polymer for removing makeup on the skin
CN110062619A
Solid anhydrous composition for removing the makeup on the skin
WO2016058180A1
Porous silica particles and cleansing cosmetic product
WO2016072456A1
Porous silica particle composition
WO2020071539A1